Holter Monitors

VectraCor designs and manufactures portable diagnostic medical devices that enable primary care, urgent care, and telemedicine environments to perform cardiac and pulmonary testing. The company specializes in ECG systems, Holter monitoring, and spirometry platforms that integrate with standard tablets and laptops, reducing infrastructure costs while maintaining clinical-grade diagnostics. The VectraplexECG system uses patented 5-electrode technology to derive 15–22 lead ECG traces and detect changes suggestive of acute coronary events via the proprietary Cardiac Electrical Biomarker (CEB®). The V300 Holter monitor provides continuous ambulatory cardiac monitoring with cloud-based data transfer and EMR integration. The Orbit™ Spirometer delivers pulmonary function testing with mobile deployment. All devices are FDA-cleared, CE-marked, and manufactured under ISO 13485 certification. VectraCor products emphasize durable, portable design for point-of-care diagnostics and remote monitoring workflows, with integrated EMR connectivity to major health systems and email-based report distribution.

Medicalgorithmics S.A. is a Warsaw-based, publicly listed (GPW) medical technology company founded in 2005, specializing in AI-powered, noninvasive cardiac diagnostic solutions. The company develops and manufactures a comprehensive suite of ECG monitoring devices and cloud-based software platforms that leverage advanced artificial intelligence to detect, classify, and analyze cardiac arrhythmias. Key product offerings include PocketECG (full-disclosure mobile cardiac telemetry with rich diagnostic reporting), Kardiobeat.ai (wearable 24–18 day Holter monitor with AI-driven analysis), DeepRhythm Platform (DRP) – a hardware-agnostic cloud ECG platform with FDA clearance and Health Canada licensing – DeepRhythmAI (DRAI) for rapid arrhythmia detection across third-party devices, and Virtual Cardiac Stress Test (VCAST), an advanced CT-based diagnostic tool for coronary artery assessment. All core products carry FDA 510(k) clearance, EU MDR certification, and Health Canada approval. The company serves cardiologists, healthcare systems, and clinical research organizations across North America, Europe, and Asia-Pacific, with an extensive annotated heartbeat library supporting over 100 arrhythmia types. Medicalgorithmics also provides R&D services, clinical trial support, and scientific research partnerships focused on cardiovascular disease diagnosis.

Biotricity Inc. is a publicly traded medical technology company (NASDAQ-listed, 2021) specializing in remote cardiac monitoring and chronic disease management solutions. Founded in 2010 and headquartered in Redwood City, California, the company develops FDA-cleared wearable cardiac monitoring devices and cloud-based platforms for continuous biometric data collection and analysis. Biotricity's product portfolio includes Bioflux® (mobile cardiac telemetry), Biocore (3-channel ECG Holter monitor with 30-day recording), Bioheart (consumer-grade continuous heart rate monitoring), Biokit (multi-vital remote patient monitoring kit), and Biocare (chronic disease management platform). The company operates a dual-revenue model combining recurring Technology-as-a-Service (TaaS) monitoring fees with device hardware sales. Biotricity serves both clinical providers and direct-to-consumer markets, with trusted monitoring for over 100,000+ patients. The platform emphasizes faster diagnosis (3-5 days vs. 2-3 weeks), wireless data transmission via Bluetooth, and physician-reviewed analysis by cardiologists. Biotricity addresses the growing demand for telehealth and proactive cardiac care management, reducing patient risk and improving clinical outcomes.

Lynn Medical is a family-owned specialty medical distributor based in Wixom, Michigan, with over 56 years of proven expertise serving the healthcare market. Founded in 1966, the company distributes diagnostic supplies and equipment with a focus on cardiology and imaging procedures. Lynn Medical serves more than 2,000 healthcare specialty practices, physician offices, clinics, hospitals, and laboratories nationwide. The company maintains partnerships with over 100 manufacturers and stocks more than 150,000 products, including cardiac catheterization equipment, ECG systems, patient monitoring devices, ultrasound supplies, electrodes, IV and infusion products, PPE, disinfection products, and point-of-care assays. With a team of 30+ clinical professionals offering technical expertise and consultation, Lynn Medical provides comprehensive solutions designed to improve patient management and reduce healthcare costs, backed by competitive pricing, reliable inventory management, and responsive customer service.

DMS-Service, LLC is a specialized provider of Holter monitoring equipment and cardiac monitoring services. The company manufactures and distributes the myPatch®sl Holter recorder, a wearable, patch-based ECG monitoring device designed for continuous cardiac rhythm recording. The myPatch®sl features 2–3 channel ECG capability with recording durations of up to 14 days (2-channel) or 9 days (3-channel), IP68 water-resistance rating, multiple electrode sizes (Adult, Pediatric, Neonate, and T-electrode), wireless operation, and rechargeable battery technology. The device is designed for patient comfort and compliance, with easy application (snap, peel, stick methodology) and a double-tap event marker feature. DMS-Service offers 24/7/365 Holter scanning and analysis services, supporting medical practices with cardiac monitoring workflow integration. The company provides compatibility with major Holter analysis software systems and practice support services. Products are marketed toward cardiology practices, clinics, and healthcare providers requiring non-invasive ambulatory ECG monitoring. The organization has a long-standing track record in the cardiac monitoring sector, with customer testimonials from cardiologists and research institutions, including Washington University School of Medicine.

Diagnostic Monitoring Software (DMS) specializes in advanced outpatient cardiac telemetry and electrocardiogram (ECG) monitoring systems for clinical practices. The company manufactures and distributes the Real-time Outpatient Cardiac Telemetry (ROCT) system, a 6-lead Mobile Cardiac Telemetry (MCT) patch device paired with sophisticated ECG analysis and Holter reanalysis software. Primary product offerings include the ROCT MCT patch for continuous cardiac monitoring, detection of arrhythmias, conduction defects, ST-segment abnormalities, atrial fibrillation, and sleep apnea; the ROCT-Connect management database with EMR integration for streamlined ordering, tracking, electronic signatures, and automated billing; and legacy Holter-based monitoring systems. The ROCT system is marketed as a high-diagnostic-yield alternative to conventional 1–3 lead telemetry devices, with full ECG data disclosure and advanced signal processing for P-wave analysis. DMS provides both in-house monitoring capabilities via ROCT-Connect and partnerships with Intelli-Heart Services for full-service concierge MCT monitoring. The company has deep heritage in cardiac monitoring innovation, tracing its origins to collaborations with Norman Holter and Dr. William Parsons in 1962. Services include EMR integration, patient telemetry management, and diagnostic interpretation support for electrophysiologists and interventional cardiologists. Primary markets are outpatient cardiology practices, cardiac rehabilitation programs, and hospital-based electrophysiology departments.

iRhythm Technologies develops and provides ambulatory cardiac monitoring solutions for arrhythmia detection and diagnosis. The company's primary offering is the Zio ECG monitoring service, a wearable long-term cardiac monitoring platform designed for continuous, uninterrupted patient monitoring. The Zio service includes several key components: the Zio monitor (wearable device), advanced AI-assisted analysis utilizing FDA-cleared deep-learning algorithms verified by Qualified Cardiac Technicians (QCTs), and comprehensive physician-ready reports. The service supports both continuous monitoring and event-triggered detection capabilities. iRhythm serves healthcare professionals including cardiologists, electrophysiologists, and primary care providers. The company has processed data from over 12 million patients and 2 billion hours of curated heartbeat data. Key technological features include FDA-cleared AI algorithms (available in the US, EU, Switzerland, UK, and Japan), integration with electronic health records (EHR) systems, and a clinician portal (ZioSuite) for report interpretation and patient management. The MyZio patient app provides digital symptom logging, educational content, and wear compliance support. Clinical evidence indicates the Zio LTCM service achieves the highest diagnostic yield of specified arrhythmias compared to other monitoring strategies, lowest likelihood of retesting, and 99% physician agreement with comprehensive end-of-wear reports. The company maintains robust clinical validation through prospective and retrospective studies including the AVALON and CAMELOT studies. iRhythm supports patients, healthcare professionals, and international inquiries through dedicated support channels.

EdanUSA is a San Diego-based distributor and service center for FDA-approved diagnostic medical equipment, established in 2009 to provide U.S. local support and inventory. The company stocks over $1 million in diagnostic equipment and spare parts, serving over 100 resellers across the United States. EdanUSA specializes in high-quality, cost-effective diagnostic devices including patient monitors, ECG/EKG machines, ultrasound systems, fetal monitors, Holter monitors, pulse oximeters, colposcopes, Dopplers, and vital sign monitoring equipment. All products are backed by a three-year manufacturer warranty with on-site customer service and factory-trained engineers guaranteeing 24-48 hour service turnaround. The company offers pricing 30-40% below major U.S. competitors while maintaining comprehensive support through a dedicated service center, learning resources, and EMR connectivity assistance.

NorthEast Monitoring is a medical device manufacturer specializing in ambulatory cardiac monitoring solutions. The company invented the world's first 14-day dual Holter and event recorder and manufactures a range of Holter recorders and event recording devices including the DR400 patch-style recorder and DR200 Holter recorder. Product offerings include both hardware (portable cardiac monitoring devices) and proprietary analysis software (HE/LX® Analysis, LX® Event, LX® Remote) designed for flexible deployment across office, hospital, and scanning service environments. The company serves physicians' offices, hospitals, and independent scanning services with solutions that streamline cardiac data collection, analysis, and remote transmission via HIPAA-compliant web portals. NorthEast Monitoring emphasizes user-friendly design, high-quality manufacturing, and an industry-leading 3-year warranty. The company has assembled a team with combined 180 years of healthcare experience across nursing, cardiology, health insurance, software engineering, and electrical engineering disciplines. Manufacturing and support capabilities include technical training videos, comprehensive documentation, and world-class customer support. Founded and led by President Mark Hubelbank Ph.D., an engineering physicist with 45 years of experience in medical research and product development in technology-based medical instrumentation.

Global Instrumentation, LLC provides customized cardiac diagnostic and monitoring solutions for clinical researchers, contract research organizations, core labs, remote cardiac monitoring service providers, and medical technology OEMs. The company specializes in precision ECG data collection, ambulatory blood pressure monitoring (ABPM), and enterprise-level data management platforms for cardiac safety assessment in clinical trials (Phase 1–5). Product portfolio includes the M5 Wearable ECG Recorder (ultra-compact, 21-day ambulatory recording capability), M12R Holter & ECG Recorder (simultaneous 12-lead real-time and long-term monitoring), M12R Lite (portable 12-lead acquisition with Bluetooth connectivity), M12A Enterprise Software Platform (scalable cloud-based data acquisition, management, and analysis system for ECG and ABP data), and Oscar 2 Ambulatory Blood Pressure Monitor (24-hour ABPM standard). The M12A platform integrates multiple devices and enables centralized data collection, analytics, reporting, and secure storage across geographically distributed trials. Solutions are used in thousands of clinical trials globally. The company emphasizes patient-friendly device design, flexible cloud deployment, precision analytics, and streamlined regulatory submission workflows. Services include custom software development and OEM partnerships for cardiac sensors and monitoring systems.

LifeSignals, Inc. is a medical device company specializing in wireless patient monitoring solutions and disposable wearable biosensors for in-hospital, hospital-at-home, and ambulatory care settings. The company develops the UbiqVue™ platform, a cloud-based wireless patient monitoring system that captures continuous vital signs including 2-channel ECG and multiparameter vital signs through single-use, cost-effective biosensors. LifeSignals' patented LSP silicon platform enables disposable sensors designed for mass production, reducing clinical device costs while maintaining clinical-grade accuracy. The UbiqVue Multiparameter system provides near real-time vital sign monitoring for large-scale in-hospital and hospital-at-home delivery; the UbiqVue Holter system delivers cloud-based ECG analysis and reporting for ambulatory cardiac services and mobile cardiac telemetry (MCT). Core technology includes Wi-Fi-centric wireless connectivity with support for multiple radios, HIPAA and GDPR-compliant data transfer, and robust encryption. The company serves healthcare providers, integrated delivery networks, and digital health platforms seeking to untether patients from wired monitoring constraints while enabling data-driven clinical insights. LifeSignals operates manufacturing and integration capabilities with headquarters in Milpitas, CA, and regional offices in India, Europe (Ireland), and Asia-Pacific (Singapore), supporting global deployment of wireless healthcare monitoring infrastructure across population health initiatives.

Huxley Medical, Inc. develops FDA-cleared wearable diagnostic patches and cloud-based software platforms for integrated cardiosleep assessment. The company's flagship product, SANSA® (Sleep Apnea and Nocturnal Symptom Assessment), is a single-use, wireless, cellular-enabled patch that captures nine channels of physiological data—including ECG, SpO2, heart rate, respiratory effort, chest movement, body position, actigraphy, snoring, and sleep/wake staging—to diagnose obstructive sleep apnea and detect cardiac arrhythmias including atrial fibrillation in a home-based setting. SANSA® has received FDA 510(k) clearance for sleep apnea testing, diagnostic ECG capabilities, and central sleep apnea detection. The device has been validated in multi-site clinical trials against gold-standard polysomnography (PSG). Huxley's software platform, Huxley HUB™, is a HIPAA-compliant cloud portal offering real-time data management, epoch-by-epoch sleep review, AI-powered auto-scoring at 3% and 4% hypopnea thresholds, customizable reporting templates, and direct report delivery to sleep specialists and cardiologists. The company targets sleep medicine practices, cardiology clinics, and primary care settings seeking to streamline sleep apnea diagnosis, reduce diagnostic backlogs, and integrate cardiosleep assessment without lengthy referrals or multiple in-clinic visits. SANSA Express™ offers direct-to-patient shipping with 24/7 live support. Regulatory credentials include FDA 510(k) clearance and HIPAA compliance. Manufacturing and service capabilities include cellular-enabled wearable patch design, cloud-native platform architecture, and direct patient logistics.

Danlee Medical Products, Inc. is a women-owned, FDA-regulated manufacturer and distributor of cardiology equipment, supplies, and consumables. For over 25 years, the company has served as a one-stop source for healthcare facilities, medical offices, and supply companies, specializing in products for EKG/ECG testing, Holter monitoring, stress testing, echo/ultrasound, blood pressure monitoring, and vital sign assessment. The company manufactures customized hook-up kits for event recording and Holter monitor testing, and distributes a comprehensive catalog including ECG electrodes (including their proprietary Fantabstic® Resting Tab Electrode #3000), abrasive skin prep pads (Scrubbies®), chart paper, patient monitor cables, leadwires, stethoscopes, pulse oximeters, blood pressure cuffs, examination gloves, and related accessories. Danlee is an authorized distributor of major brands including 3M, Ambu, Burdick, Cardiac Science, ConMed, Dynarex, Edan USA, GE Healthcare, Medtronic, Mortara, Philips, Schiller, and Welch Allyn. The company operates a full e-commerce platform with fast order processing, secure purchasing, archived order history, and same-day customer service support. Danlee maintains regulatory compliance as an FDA-regulated entity and is recognized as a nationally certified women-owned business enterprise. Products serve hospitals, cardiology clinics, ambulatory surgery centers, and medical supply companies across the U.S. and globally.

Icentia is a medical devices manufacturer and service company specializing in innovative solutions for long-term cardiac monitoring and ECG testing in institutional healthcare settings. The company's flagship product is CardioSTAT®, a compact, lightweight, and patient-comfortable continuous ECG recorder designed for ambulatory cardiac rhythm diagnosis. CardioSTAT features high-quality single-lead ECG recordings optimized for extended wear, combining clinical accuracy with superior patient compliance. The device has achieved FDA clearance in the United States and is used extensively across Canadian academic medical centers and cardiac institutes. Icentia has established partnerships with leading academic institutions including Institut Universitaire de Cardiologie et de Pneumologie de Québec, Institut de Cardiologie de Montréal, Ottawa Heart Institute, and Hamilton Health Sciences. The company has demonstrated significant growth, ranking among Canada's top growing companies for four consecutive years (2019–2022). Icentia maintains robust data collection and analysis capabilities, having compiled the largest public single-lead ECG dataset of 11,000 patients with 2 billion annotated beats. The CardioSTAT system has surpassed 100,000 completed tests, establishing clinical credibility in arrhythmia detection and continuous cardiac monitoring. The company operates as both a device manufacturer and service provider, leveraging partnerships with research institutions including Mila (Montreal Institute for Learning Algorithms). Icentia serves institutional healthcare markets across North America with a focus on cardiac diagnostic excellence and clinician-friendly workflow integration.

Norav Medical is a cardiac diagnostic equipment manufacturer headquartered in Delray Beach, Florida, operating since 1993. The company specializes in electrocardiograph (ECG) systems and ancillary cardiology devices for hospitals, primary care practices, emergency departments, cardiology clinics, and clinical research settings. Product portfolio includes: Resting ECG systems (conventional and all-in-one models), Stress ECG with medical-grade treadmills and ergometers, Holter ECG for ambulatory monitoring, Ambulatory Blood Pressure Monitoring (ABPM), Spirometry systems for pulmonary function testing, ECG Telemetry/Cardiac Rehab monitoring systems, and a mobile ECG application (iOS, Android, Windows). The company also offers ECG management software with HL7, GDT, and DICOM connectivity for hospital information systems integration. Norav maintains FDA clearance, CE marking, MDSAP certification, ISO 13485 compliance, and HIPAA/GDPR data security certifications. Manufacturing emphasizes signal quality, automatic ECG interpretation, wireless and wired acquisition capabilities, and customizable solutions. The company provides localized technical support, on-demand service, custom software development, and equipment upgrade services. Key markets include acute-care hospitals, cardiology diagnostic centers, primary care offices, emergency medicine, and clinical trial research. The company serves diverse clinical segments with flexible, durable equipment designed for heavy use in challenging environments. In-house software development enables rapid customization and integration with existing hospital IT infrastructure.

Spacelabs Healthcare manufactures patient monitoring systems, diagnostic cardiology equipment, and clinical informatics solutions for acute care, ICU, emergency department, neonatal, and perioperative settings. Core product lines include bedside monitors (Xprezzon, Qube, C50), telemetry systems (AriaTele), central surveillance (Xhibit XC48, XC4), resting ECG systems (CardioExpress series 4012, 5012, SL18A, SL12A, SL6A), Holter monitors and event recorders (Eclipse Pro, Eclipse Mini, Pathfinder SL), and ambulatory blood pressure monitoring (OnTrak, 90217A). The company also offers clinical software tools including SafeNSound Care Coordination (SaaS), Clinical Access, Custom Trends, Print Manager, Smart Disclosure, and Vital Signs Viewer, along with networking and integration solutions (XprezzNet, Flexport interfaces) for EMR connectivity. Spacelabs emphasizes situation awareness design, clinical informatics, and care team performance optimization through its Runway architecture and TeamUp strategies. The company traces its heritage to NASA space program cardiac monitoring development and serves hospitals and healthcare systems across multiple care settings. Technical support includes product manuals, cleaning instructions, service contracts, and cybersecurity advisories.

Datrix LLC is a commercial ambulatory ECG device manufacturer established in 1988 and incorporated as an LLC in 2017. The company designs, manufactures, and distributes Holter monitors and ambulatory cardiac monitoring devices to dealers and medical equipment companies globally. Primary products include the VX3 Holter Recorder, a traditional 3-channel device available in 5 or 7-wire configurations, and the Sirona, a versatile 4-in-1 ambulatory monitor supporting event, post-event, and Holter monitoring modes with configurable lead options or patch-based monitoring. Datrix maintains ISO 13485 certification and FDA registration for its manufacturing facility, ensuring compliance with FDA Quality Systems Regulations. The company leverages strategic relationships with ISO 13485-registered contract manufacturers in Asia to support its production capabilities. Quality systems emphasize design and process validation, equipment qualification, lot traceability, and compliance testing, with continuous improvement through Lean Manufacturing practices. Datrix serves the ambulatory cardiac monitoring segment, supporting clinical requirements for long-term heart rhythm monitoring in diverse care settings.

VasoMedical, Inc. is a cardiovascular technology company with nearly 40 years of experience in cardiac diagnostics and therapy. The company specializes in two primary product areas: Enhanced External Counterpulsation (EECP®) therapy systems and next-generation cardiac monitoring platforms. Their Lumenair™ EECP® system is deployed in over 600 clinics across 40+ countries and is used for non-invasive therapy to improve coronary circulation, helping patients with angina and heart failure improve exercise tolerance and quality of life. In cardiac monitoring, VasoMedical offers the ARCS cloud-native platform, an FDA-cleared system for Holter, Extended Holter, Event, and Multi-Channel Telemetry (MCT) monitoring. ARCS features artifact-reduction algorithms, unified workflow management, and high-volume scanning capabilities designed to reduce manual rework and accelerate turnaround times. The company has analyzed over 1 billion heartbeats and delivered 12+ million hours of cardiac monitoring data. VasoMedical also provides the Advanced Cardiac Therapy (ACT) Program, a comprehensive utilization and operations model to help health systems optimize EECP program performance across cardiology, rehabilitation, and administrative workflows. The company serves hospitals, cardiology practices, rehabilitation clinics, and health systems ranging from private practices to major healthcare networks. Products are supported by FDA clearance for monitoring algorithms and established reimbursement pathways. VasoMedical combines hardware, software, and operational consulting to address both clinical and workflow challenges in cardiac care.

Wearlinq manufactures the eWave, a FDA-cleared 6-lead wireless cardiac monitoring system designed for mobile cardiac telemetry and extended Holter monitoring. The device is imperceptible, featuring skin-like electrodes and a 5-day battery life per charge, with continuous data transmission to a cloud platform. The eWave captures six distinct ECG leads wirelessly, eliminating traditional wires while delivering diagnostic-grade cardiac data. The company operates Wearlinq Labs, an IDTF (Independent Diagnostic Testing Facility) with 33 years of cardiology service experience, staffed by Certified Cardiographic Technicians providing 24/7 coverage. Wearlinq delivers high-quality cardiology reports within 2 days and produces STAT reports daily. The platform includes a mobile application enabling real-time access to EKG data, digital diary functionality to correlate symptoms with cardiac events, connectivity monitoring to ensure signal quality, and 24/7 patient concierge support. The company targets cardiology practices, outpatient facilities, and hospitals requiring remote cardiac monitoring capabilities. Wearlinq received FDA clearance for the eWave and recently raised $14 million in funding, indicating active development and market expansion in the cardiac monitoring sector.